Sarah J Welsh

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Renal Cell Carcinoma

Fluorescence Imaging

Randomized Controlled Trial

Top Venues

BJU international

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Martin H Voss, Arun A Azad, Aaron Richard Hansen, Jhanelle E Gray, Sarah J Welsh, Xuyang Song, Michael Kuziora, Lina Meinecke, Jorge M Blando, Ikbel Achour, Yi Wang, Farzana L Walcott, Sjoukje F Oosting
A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (14) (2022)
Stephan Ursprung, Ramona Woitek, Mary A McLean, Andrew N Priest, Mireia Crispin-Ortuzar, Cara R Brodie, Andrew B Gill, Marcel Gehrung, Lucian Beer, Antony C P Riddick, Johanna Field-Rayner, James T Grist, Surrin Shazam Deen, Frank Riemer, Joshua D Kaggie, Fulvio Zaccagna, Joao A G Duarte, Matthew J Locke, Amy Frary, Tevita F Aho, James N Armitage, Ruth Casey, Iosif A Mendichovszky, Sarah J Welsh, Tristan Barrett, Martin J Graves, Tim Eisen, Thomas J Mitchell, Anne Y Warren, Kevin M Brindle, Evis Sala, Grant D Stewart, Ferdia A Gallagher
Hyperpolarized 13 C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma-A Proof of Principle Study. Cancers 14 (2) (2022)
Sarah J Welsh, Nicola Thompson, Anne Warren, Andrew N Priest, Tristan Barrett, Stephan Ursprung, Ferdia A Gallagher, Fulvio Zaccagna, Grant D Stewart, Kate M Fife, Athena Matakidou, Andrea J Machin, Wendi Qian, Victoria Ingleson, Jean Mullin, Antony C P Riddick, James N Armitage, Stephen Connolly, Timothy G Q Eisen
Dynamic biomarker and imaging changes from a phase II study of pre- and post-surgical sunitinib. BJU international (2021)
Helen Mossop, Michael John Grayling, Ferdia A Gallagher, Sarah J Welsh, Grant D Stewart, James M S Wason
Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials. British journal of cancer (2021)
Rafia S Al-Lamki, Nicholas J Hudson, John R Bradley, Anne Y Warren, Tim Eisen, Sarah J Welsh, Antony C P Riddick, Fiach C O'Mahony, Arran Turnbull, Thomas Powles, null Scotrrcc Collaborative, Antonio Reverter, David J Harrison, Grant D Stewart
The Efficacy of Sunitinib Treatment of Renal Cancer Cells Is Associated with the Protein PHAX In Vitro. Biology 9 (4) (2020)